- Home
- RILY vs SGMO Comparison
RILY vs SGMO Comparison
Compare RILY & SGMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RILY
- SGMO
- Stock Information
- Founded
- RILY 1973
- SGMO 1995
- Country
- RILY United States
- SGMO United States
- Employees
- RILY N/A
- SGMO N/A
- Industry
- RILY Investment Managers
- SGMO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- RILY Finance
- SGMO Health Care
- Exchange
- RILY Nasdaq
- SGMO Nasdaq
- Market Cap
- RILY 185.4M
- SGMO 180.5M
- IPO Year
- RILY 2007
- SGMO 2000
- Fundamental
- Price
- RILY $5.05
- SGMO $1.88
- Analyst Decision
- RILY
- SGMO Buy
- Analyst Count
- RILY 0
- SGMO 3
- Target Price
- RILY N/A
- SGMO $7.00
- AVG Volume (30 Days)
- RILY 1.3M
- SGMO 9.9M
- Earning Date
- RILY 12-03-2024
- SGMO 11-12-2024
- Dividend Yield
- RILY 39.60%
- SGMO N/A
- EPS Growth
- RILY N/A
- SGMO N/A
- EPS
- RILY N/A
- SGMO N/A
- Revenue
- RILY $1,221,832,000.00
- SGMO $52,291,000.00
- Revenue This Year
- RILY N/A
- SGMO N/A
- Revenue Next Year
- RILY N/A
- SGMO $71.79
- P/E Ratio
- RILY N/A
- SGMO N/A
- Revenue Growth
- RILY 19.73
- SGMO N/A
- 52 Week Low
- RILY $4.07
- SGMO $0.30
- 52 Week High
- RILY $40.09
- SGMO $3.18
- Technical
- Relative Strength Index (RSI)
- RILY 46.55
- SGMO 49.56
- Support Level
- RILY $4.52
- SGMO $1.82
- Resistance Level
- RILY $4.93
- SGMO $2.11
- Average True Range (ATR)
- RILY 0.34
- SGMO 0.37
- MACD
- RILY -0.01
- SGMO -0.10
- Stochastic Oscillator
- RILY 44.92
- SGMO 10.96
About RILY B. Riley Financial Inc.
B. Riley Financial Inc is a diversified financial services company. The company through its subsidiaries offers investment banking and financial services to corporate, institutional, and high-net-worth clients and also asset disposition, valuation and appraisal, and capital advisory services to retail, wholesale, institutional, lenders, capital providers, private equity investors, and professional services firms in United States, Canada, and Europe. It also provides internet access and subscription services. The reportable operating segments of the company include Capital Markets, Wealth Management, Financial Consulting, Auction and Liquidation, Communications segment, and Consumer products segment.
About SGMO Sangamo Therapeutics Inc.
Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.